These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 20404117

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Moderate-level resistance to glycopeptide LY333328 mediated by genes of the vanA and vanB clusters in enterococci.
    Arthur M, Depardieu F, Reynolds P, Courvalin P.
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1875-80. PubMed ID: 10428906
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Emergence of vanA Genotype Vancomycin-Resistant Enterococci with Low or Moderate Levels of Teicoplanin Resistance in Korea.
    Eom JS, Hwang IS, Hwang BY, Lee JG, Lee YJ, Cheong HJ, Park YH, Park SC, Kim WJ.
    J Clin Microbiol; 2004 Apr; 42(4):1785-6. PubMed ID: 15071050
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro stepwise selection of reduced susceptibility to lipoglycopeptides in enterococci.
    Arhin FF, Seguin DL, Belley A, Moeck G.
    Diagn Microbiol Infect Dis; 2017 Oct; 89(2):168-171. PubMed ID: 28733126
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Genetics of glycopeptide resistance in enterococci.
    Evers S, Quintiliani R, Courvalin P.
    Microb Drug Resist; 1996 Oct; 2(2):219-23. PubMed ID: 9158763
    [Abstract] [Full Text] [Related]

  • 12. Lipophilic teicoplanin pseudoaglycon derivatives are active against vancomycin- and teicoplanin-resistant enterococci.
    Szűcs Z, Bereczki I, Csávás M, Rőth E, Borbás A, Batta G, Ostorházi E, Szatmári R, Herczegh P.
    J Antibiot (Tokyo); 2017 May; 70(5):664-670. PubMed ID: 28144040
    [Abstract] [Full Text] [Related]

  • 13. Comparison of vanA gene mRNA levels between vancomycin-resistant Enterococci presenting the VanA or VanB phenotype with identical Tn1546-like elements.
    Shen H, Liu Y, Qu J, Cao B.
    J Microbiol Immunol Infect; 2016 Dec; 49(6):866-871. PubMed ID: 25556043
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Substrate Inhibition of VanA by d-Alanine Reduces Vancomycin Resistance in a VanX-Dependent Manner.
    van der Aart LT, Lemmens N, van Wamel WJ, van Wezel GP.
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4930-9. PubMed ID: 27270282
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characterization of an Enterococcus gallinarum Isolate Carrying a Dual vanA and vanB Cassette.
    Eshaghi A, Shahinas D, Li A, Kariyawasam R, Banh P, Desjardins M, Melano RG, Patel SN.
    J Clin Microbiol; 2015 Jul; 53(7):2225-9. PubMed ID: 25948610
    [Abstract] [Full Text] [Related]

  • 19. Pharmacodynamics of telavancin studied in an in vitro pharmacokinetic model of infection.
    MacGowan AP, Noel AR, Tomaselli S, Elliott HC, Bowker KE.
    Antimicrob Agents Chemother; 2011 Feb; 55(2):867-73. PubMed ID: 21078943
    [Abstract] [Full Text] [Related]

  • 20. Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates.
    Bell JM, Paton JC, Turnidge J.
    J Clin Microbiol; 1998 Aug; 36(8):2187-90. PubMed ID: 9665988
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.